Published in Healthcare Finance, Tax and Law Weekly, January 4th, 2006
For the quarter ended October 31, 2005, Alexion reported revenues of $0.5 million compared to $0.1 million for the same period last year. The company had increased activity related to government funded research grants compared to the same period last year.
Total operating expenses for the quarter were $36.8 million compared to $22.3 million in the same quarter last year. The company's research and development expenses for the 3-month period ended October 31, 2005, were $30.3 million compared to $18.7 million for the same period last...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly